Please Wait
Applying Filters...
menu
    • menu
    J&J’s Intra‑Cellular buyout, BMS’ oncology gambit, Sanofi’s Blueprint acquisition drive mega deals in H1 2025

    Data Compilation
    #PharmaFlow

    Pipeline Prospector June 2025: Sanofi, AbbVie, Eli Lilly, BioNTech lead pharma M&A spree; BMS, Astra ink major collaborations

    Stock Recap
    #PipelineProspector

    Menu

    Rivastigmine (transdermal patch)

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 2,013Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to access your PharmaMiles and download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    28/06/2025 Interquim SA
    Spain
    		 Samyang Holdings Co., Ltd. 20170821-184-I-519-16(2) Rivastigmine 2017-12-08 Interquim, SA Spain c/ Joan Buscallà,10, 08173 Sant Cugat Del Vallès (Barcelona), Spain
    28/06/2025 Interquim SA
    Spain
    		 Shinil Pharmaceutical Co., Ltd. 20170821-184-I-519-16(1) Rivastigmine 2017-11-27 Interquim, SA Spain c/ Joan Buscalla, 10, 08173 Sant Cugat del Vallaes (Barcelona), Spain